Merck Total Current Liabilities 2010-2024 | MKKGY

Merck total current liabilities from 2010 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
  • Merck total current liabilities for the quarter ending June 30, 2024 were $10.695B, a 10.88% increase year-over-year.
  • Merck total current liabilities for 2023 were $9.415B, a 6.07% decline from 2022.
  • Merck total current liabilities for 2022 were $10.023B, a 18.79% decline from 2021.
  • Merck total current liabilities for 2021 were $12.342B, a 17.05% increase from 2020.
Merck Annual Total Current Liabilities
(Millions of US $)
2023 $9,415
2022 $10,023
2021 $12,342
2020 $10,545
2019 $13,263
2018 $10,059
2017 $9,760
2016 $10,055
2015 $10,412
2014 $8,775
2013 $5,179
2012 $5,867
2011 $6,077
2010 $
2009 $
Merck Quarterly Total Current Liabilities
(Millions of US $)
2024-06-30 $10,695
2024-03-31 $10,791
2023-12-31 $9,415
2023-09-30 $9,453
2023-06-30 $9,646
2023-03-31 $10,257
2022-12-31 $10,023
2022-09-30 $9,480
2022-06-30 $10,342
2022-03-31 $11,454
2021-12-31 $12,342
2021-09-30 $11,548
2021-06-30 $11,832
2021-03-31 $12,842
2020-12-31 $10,545
2020-09-30 $11,350
2020-06-30 $11,099
2020-03-31 $11,875
2019-12-31 $13,263
2019-09-30 $10,736
2019-06-30 $11,796
2019-03-31 $12,714
2018-12-31 $10,059
2018-09-30 $10,425
2018-06-30 $9,859
2018-03-31 $10,489
2017-12-31 $9,760
2017-09-30 $9,614
2017-06-30 $9,823
2017-03-31 $9,942
2016-12-31 $10,055
2016-09-30 $9,498
2016-06-30 $9,506
2016-03-31 $9,967
2015-12-31 $10,412
2015-09-30 $5,860
2015-06-30 $5,881
2015-03-31 $5,997
2014-12-31 $8,775
2014-09-30 $7,733
2014-06-30 $7,065
2014-03-31 $7,008
2013-12-31 $5,179
2013-09-30 $5,404
2013-06-30 $5,869
2013-03-31 $6,103
2012-12-31 $5,867
2012-09-30 $6,252
2012-06-30 $5,055
2012-03-31
2011-12-31 $6,077
2011-09-30
2011-06-30 $5,115
2011-03-31
2010-12-31
2010-09-30 $4,969
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical MED-DRUGS $21.306B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
New York Community Bancorp (FLG) United States $4.269B 0.00
Acasti Pharma (GRCE) Canada $0.033B 0.00